AMICUS THERAPEUTICS, INC. (FOLD)

14.34 -0.02 (-0.14%)

As of 2026-03-03 04:13:32 EST

Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.

Traded asNasdaq: FOLD
ISINUS03152W1099
CIK0001178879
LEI549300MRD1SMUTNBPQ53
EIN200422823
SectorBiotechnology
IndustryPharmaceutical Preparations
CEO—
Employees508
Fiscal Year End1231
Address47 HULFISH STREET, PRINCETON, NJ, 08542
Phone(609) 662-2000
Websitehttps://www.amicusrx.com/
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
FOLDAMICUS THERAPEUTICS, INC.2026-03-03 04:13:3214.34-0.02-0.14
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
FOLD0001178879AMICUS THERAPEUTICS, INC.US03152W1099549300MRD1SMUTNBPQ53200422823Nasdaq2834Pharmaceutical Preparations1231DE47 HULFISH STREETPRINCETONNJ08542UNITED STATESUS(609) 662-200047 HULFISH STREET, PRINCETON, NJ, 0854247 HULFISH STREET, PRINCETON, NJ, 08542AMICUS THERAPEUTICS INCBiotechnology2002-02-04—508https://www.amicusrx.com/1,744,699,397310,853,963314,000,712Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.2026-02-26 16:46:45
This is a preview of the latest data. Subscribe to access the full data.
FOLD Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
FOLD Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
20251,744,699,397-1,195,875,063-40.6681314,000,71213,884,6314.6264
20242,940,574,460-616,374,057-17.3287300,116,0814,733,4671.6025
20233,556,948,517577,125,13119.3678295,382,61412,667,8764.4808
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Ellen S. RosenbergChief Legal Officer, Corporate Secretary2024514,423332,8862,048,280—40,4753,800,307
David M. ClarkChief People Officer2024482,903270,1971,564,136—38,0063,015,209
Bradley L. CampbellChief Executive Officer, President2024767,308623,7004,990,365—39,9438,526,943
Simon HarfordChief Financial Officer2024514,423275,3191,862,083—11,5623,449,065
Jeffrey P. CastelliChief Development Officer2024491,807263,4941,862,083—39,8343,442,896
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
2025511
2024499
2023517
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202520242023
Revenue634,210,000528,295,000399,356,000
Cost Of Revenue72,929,00052,943,00037,326,000
Gross Profit561,281,000475,352,000362,030,000
Research And Development Expenses135,843,000109,362,000152,381,000
General And Administrative Expenses383,487,000323,379,000275,270,000
Operating Expenses528,492,000450,476,000439,241,000
Operating Income32,789,00024,876,000-77,211,000
Net Income-27,110,000-56,106,000-151,584,000
Earnings Per Share Basic-0.09-0.18-0.51
Earnings Per Share Diluted-0.09-0.18-0.51
Weighted Average Shares Outstanding Basic308,363,768304,380,502295,164,515
Weighted Average Shares Outstanding Diluted308,363,768304,380,502295,164,515
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202520242023
Cash And Cash Equivalents214,010,000213,752,000246,994,000
Marketable Securities Current79,526,00036,194,00039,206,000
Accounts Receivable115,307,000101,099,00087,632,000
Inventories228,819,000118,782,00059,696,000
Non Trade Receivables———
Other Assets Current———
Total Assets Current676,173,000504,736,000483,061,000
Marketable Securities Non Current———
Property Plant And Equipment27,108,00029,383,00031,667,000
Other Assets Non Current13,739,00013,641,00018,553,000
Total Assets Non Current273,697,000280,297,000294,819,000
Total Assets949,870,000785,033,000777,880,000
Accounts Payable28,630,00012,947,00015,120,000
Deferred Revenue———
Short Term Debt———
Other Liabilities Current———
Total Liabilities Current237,828,000148,702,000167,689,000
Long Term Debt392,660,000390,111,000387,858,000
Other Liabilities Non Current4,179,0007,097,00013,282,000
Total Liabilities Non Current437,801,000442,286,000450,017,000
Total Liabilities675,629,000590,988,000617,706,000
Common Stock3,037,0002,944,0002,918,000
Retained Earnings-2,767,290,000-2,740,180,000-2,684,074,000
Accumulated Other Comprehensive Income———
Total Shareholders Equity274,241,000194,045,000160,174,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202520242023
Depreciation And Amortization7,460,0008,547,0007,873,000
Share Based Compensation Expense87,410,00084,905,00086,077,000
Other Non Cash Income Expense———
Change In Accounts Receivable5,860,00019,484,00020,108,000
Change In Inventories111,483,00073,652,00044,614,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable82,777,000-16,520,00049,195,000
Change In Other Liabilities———
Cash From Operating Activities33,145,000-33,891,000-69,091,000
Purchases Of Marketable Securities94,405,000114,786,00091,723,000
Sales Of Marketable Securities51,269,000117,779,000197,227,000
Acquisition Of Property Plant And Equipment3,296,0003,553,0007,440,000
Acquisition Of Business———
Other Investing Activities———
Cash From Investing Activities-46,432,000-560,00098,064,000
Tax Withholding For Share Based Compensation18,323,00022,025,00017,920,000
Payments Of Dividends———
Issuance Of Common Stock———
Repurchase Of Common Stock———
Issuance Of Long Term Debt———
Repayment Of Long Term Debt00408,043,000
Other Financing Activities———
Cash From Financing Activities610,0005,121,00061,677,000
Change In Cash600,000-33,361,00096,962,000
Cash At End Of Period214,010,000213,752,000246,994,000
Income Taxes Paid14,894,0008,214,0008,525,000
Interest Paid43,608,00058,960,00036,090,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202520242023
Earnings Per Share-0.09-0.18-0.51
Price To Earnings Ratio-158.2222-52.3333-27.8235
Earnings Growth Rate-50-64.7059-37.8049
Price Earnings To Growth Ratio3.16440.80880.736
Book Value Per Share0.88930.63750.5427
Price To Book Ratio16.011814.776326.149
Ebitda41,403,00010,253,000-85,037,000
Enterprise Value4,569,750,056.323,043,623,328.844,329,248,467.85
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio1.43182.01042.4215
Capital Expenditures5,185,0006,263,0008,762,000
Free Cash Flow27,960,000-40,154,000-77,853,000
Return On Equity-0.0989-0.2891-0.9464
One Year Beta0.68571.02050.8319
Three Year Beta0.79271.06231.0772
Five Year Beta0.96861.22591.2527
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
Campbell Bradley LDirector, President and CEO2026-01-2075,000A1,096,180
Campbell Bradley LDirector, President and CEO2026-01-2075,000D1,021,180
Campbell Bradley LDirector, President and CEO2026-01-2075,000D0
Clark David MichaelChief People Officer2026-01-0318,498D221,811
Prout SamanthaChief Accounting Officer2026-01-0312,240D125,951
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Daniel Goldman2023-05-19NY10Sale2023-04-10—$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
MILLENNIUM MANAGEMENT LLC2025-12-3142,650,0672,995,08914.24
Gotham Asset Management, LLC2025-12-311,987,206139,55114.24
CANADA PENSION PLAN INVESTMENT BOARD2025-12-314,068,752285,72714.24
ANGELO GORDON & CO., L.P.2025-12-311,424,000100,00014.24
Bellevue Group AG2025-12-31152,869,17710,735,19514.24
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
PIMCO VARIABLE INSURANCE TRUST2025-12-31InstitutionalPVGMAPI28,100400,1440.1384
PIMCO VARIABLE INSURANCE TRUST2025-12-31Advisor ClassVPVGMVV28,100400,1440.1384
PIMCO VARIABLE INSURANCE TRUST2025-12-31Administrative ClassVPVGMMV28,100400,1440.1384
PIMCO FUNDS2025-12-31I-3PFRMX17,300246,3520.0116
PIMCO FUNDS2025-12-31I-2PPRMX17,300246,3520.0116
This is a preview of the latest data. Subscribe to access the full data.